Stem-cell therapies for blood diseases

Claudio Bordignon ()
Additional contact information
Claudio Bordignon: Istituto Scientifico San Raffaele, Università Vita Salute

Nature, 2006, vol. 441, issue 7097, 1100-1102

Abstract: Abstract For decades, transplantation of haematopoietic stem cells — either unmodified, or genetically modified to correct genetic disorders — has been used to treat disorders of the blood and immune systems. The present challenge is to reduce the risk of such transplants and increase the number of patients who can safely access this treatment. In developing countries, such ‘one-shot’ treatments are highly desirable because chronic treatments are difficult to sustain. To make these therapies more accessible and effective it will be important to improve clinical protocols and gene-delivery vectors, and to gain a deeper understanding of stem cells.

Date: 2006
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature04962 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:441:y:2006:i:7097:d:10.1038_nature04962

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature04962

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().